Eagle Ridge Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $12.4M | Buy |
69,581
+311
| +0.4% | +$57.2K | 1.08% | 40 |
|
|
2024
Q3 | $13.7M | Sell |
69,270
-52
| -0.1% | -$9.71K | 1.2% | 35 |
|
|
2024
Q2 | $11.9M | Sell |
69,322
-1,073
| -2% | -$178K | 1.1% | 39 |
|
|
2024
Q1 | $12.8M | Sell |
70,395
-1,245
| -2% | -$215K | 1.18% | 34 |
|
|
2023
Q4 | $11.1M | Buy |
71,640
+45
| +0.1% | +$6.56K | 1.09% | 40 |
|
|
2023
Q3 | $10.7M | Sell |
71,595
-707
| -1% | -$104K | 1.16% | 33 |
|
|
2023
Q2 | $9.74M | Sell |
72,302
-267
| -0.4% | -$39.2K | 1.02% | 44 |
|
|
2023
Q1 | $11.6M | Sell |
72,569
-930
| -1% | -$142K | 1.3% | 31 |
|
|
2022
Q4 | $11.9M | Sell |
73,499
-659
| -0.9% | -$101K | 1.39% | 29 |
|
|
2022
Q3 | $9.95M | Buy |
74,158
+2,857
| +4% | +$410K | 1.25% | 36 |
|
|
2022
Q2 | $10.9M | Sell |
71,301
-831
| -1% | -$127K | 1.32% | 34 |
|
|
2022
Q1 | $11.7M | Buy |
72,132
+68
| +0.1% | +$9.88K | 1.25% | 34 |
|
|
2021
Q4 | $9.76M | Sell |
72,064
-3,244
| -4% | -$383K | 1.02% | 45 |
|
|
2021
Q3 | $8.12M | Sell |
75,308
-1,829
| -2% | -$209K | 0.9% | 49 |
|
|
2021
Q2 | $8.69M | Sell |
77,137
-1,306
| -2% | -$147K | 1.01% | 43 |
|
|
2021
Q1 | $8.49M | Sell |
78,443
-6,949
| -8% | -$743K | 1.03% | 45 |
|
|
2020
Q4 | $9.15M | Sell |
85,392
-3,504
| -4% | -$337K | 1.16% | 36 |
|
|
2020
Q3 | $7.79M | Sell |
88,896
-757
| -0.8% | -$71.3K | 1.09% | 37 |
|
|
2020
Q2 | $8.8M | Sell |
89,653
-4,986
| -5% | -$439K | 1.33% | 25 |
|
|
2020
Q1 | $7.21M | Sell |
94,639
-5,103
| -5% | -$435K | 1.25% | 27 |
|
|
2019
Q4 | $8.83M | Buy |
99,742
+82
| +0.1% | +$6.81K | 1.18% | 33 |
|
|
2019
Q3 | $7.55M | Sell |
99,660
-2,004
| -2% | -$137K | 1.09% | 40 |
|
|
2019
Q2 | $7.39M | Sell |
101,664
-861
| -0.8% | -$67.7K | 1.07% | 39 |
|
|
2019
Q1 | $8.26M | Sell |
102,525
-322
| -0.3% | -$26.3K | 1.21% | 30 |
|
|
2018
Q4 | $9.48M | Buy |
102,847
+210
| +0.2% | +$18.5K | 1.61% | 20 |
|
|
2018
Q3 | $9.71M | Sell |
102,637
-1,131
| -1% | -$107K | 1.4% | 24 |
|
|
2018
Q2 | $9.61M | Sell |
103,768
-2,451
| -2% | -$239K | 1.45% | 23 |
|
|
2018
Q1 | $10.1M | Sell |
106,219
-2,613
| -2% | -$287K | 1.55% | 23 |
|
|
2017
Q4 | $10.5M | Buy |
108,832
+523
| +0.5% | +$49.3K | 1.63% | 22 |
|
|
2017
Q3 | $9.62M | Sell |
108,309
-419
| -0.4% | -$31.9K | 1.59% | 21 |
|
|
2017
Q2 | $6.85M | Buy |
108,728
+11,834
| +12% | +$796K | 1.3% | 34 |
|
|
2017
Q1 | $6.31M | Sell |
96,894
-1,260
| -1% | -$79.2K | 1.24% | 35 |
|
|
2016
Q4 | $6.15M | Buy |
98,154
+984
| +1% | +$60.1K | 1.28% | 31 |
|
|
2016
Q3 | $6.13M | Buy |
97,170
+17,666
| +22% | +$1.14M | 1.36% | 26 |
|
|
2016
Q2 | $4.92M | Buy |
79,504
+145
| +0.2% | +$8.84K | 1.13% | 45 |
|
|
2016
Q1 | $4.53M | Sell |
79,359
-1,412
| -2% | -$78.7K | 1.06% | 48 |
|
|
2015
Q4 | $4.79M | Sell |
80,771
-3,683
| -4% | -$212K | 1.15% | 40 |
|
|
2015
Q3 | $4.59M | Buy |
84,454
+1,275
| +2% | +$83K | 1.18% | 40 |
|
|
2015
Q2 | $5.59M | Buy |
83,179
+1,850
| +2% | +$121K | 2.52% | 20 |
|
|
2015
Q1 | $4.76M | Buy |
81,329
+4,592
| +6% | +$277K | 2.16% | 25 |
|
|
2014
Q4 | $5.02M | Buy |
76,737
+443
| +0.6% | +$27.9K | 2.3% | 26 |
|
|
2014
Q3 | $4.41M | Sell |
76,294
-1,841
| -2% | -$102K | 2.12% | 27 |
|
|
2014
Q2 | $4.41M | Buy |
78,135
+635
| +0.8% | +$33.3K | 2.06% | 28 |
|
|
2014
Q1 | $3.98M | Sell |
77,500
-435
| -0.6% | -$22K | 1.94% | 32 |
|
|
2013
Q4 | $4.12M | Sell |
77,935
-1,968
| -2% | -$96.7K | 2.06% | 30 |
|
|
2013
Q3 | $3.57M | Buy |
79,903
+27
| +0% | +$1.2K | 1.98% | 30 |
|
|
2013
Q2 | $3.3M | Buy |
+79,876
| New | +$3.49M | 1.91% | 26 |
|
Other funds holding ABBV
Eagle Ridge Investment Management's ABBV Position: Q4 2024 in Review
Eagle Ridge Investment Management increased its AbbVie (ABBV) stake by 0.45% in Q4 2024, buying an estimated $57.2K and bringing the position to 69,581 shares worth $12.4M. The position accounts for 1.08% of the portfolio, ranked #40.
Eagle Ridge Investment Management first reported a position in ABBV in Q2 2013 and has held it in 47 quarters since. The position peaked at $13.7M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Eagle Ridge Investment Management held 69,581 shares of AbbVie worth $12.4M as of Q4 2024.
- Eagle Ridge Investment Management bought 311 AbbVie shares in Q4 2024, an estimated $57.2K.
- AbbVie made up 1.08% of Eagle Ridge Investment Management's portfolio in Q4 2024, its #40 holding.
- Eagle Ridge Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 47 quarters since.
- Eagle Ridge Investment Management's AbbVie position peaked at $13.7M in Q3 2024.
- 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Eagle Ridge Investment Management's 13F filing for Q4 2024, filed 27 Jan 2025.